Characterization of free radicals formed from COX-catalyzed DGLA peroxidation.

TitleCharacterization of free radicals formed from COX-catalyzed DGLA peroxidation.
Publication TypeJournal Article
Year of Publication2011
AuthorsXiao Y, Gu Y, Purwaha P, Ni K, Law B, Mallik S, Qian SY
JournalFree Radic Biol Med
Volume50
Issue9
Pagination1163-70
Date Published2011 May 01
ISSN1873-4596
Keywords8,11,14-Eicosatrienoic Acid, Anti-Inflammatory Agents, Antineoplastic Agents, Arachidonic Acid, Catalysis, Cell Line, Tumor, Chromatography, Liquid, Colonic Neoplasms, Electron Spin Resonance Spectroscopy, Free Radicals, Humans, Mass Spectrometry, Oxidation-Reduction, Peroxides, Prostaglandin-Endoperoxide Synthases, Prostaglandins, Pyridines, Spin Trapping
Abstract

Like arachidonic acid (AA), dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 polyunsaturated fatty acid and a substrate of cyclooxygenase (COX). Through free radical reactions, COX metabolizes DGLA and AA to form well-known bioactive metabolites, namely, the 1 and 2 series of prostaglandins (PGs1 and PGs2), respectively. Unlike PGs2, which are viewed as proinflammatory, PGs1 possess anti-inflammatory and anticancer activities. However, the mechanisms linking the PGs to their bioactivities are still unclear, and radicals generated in COX-DGLA have not been detected. To better understand PG biology and determine whether different reactions occur in COX-DGLA and COX-AA, we have used LC/ESR/MS with a spin trap, α-(4-pyridyl-1-oxide)-N-tert-butyl nitrone (POBN), to characterize the carbon-centered radicals formed from COX-DGLA in vitro, including cellular peroxidation. A total of five types of DGLA-derived radicals were characterized as POBN adducts: m/z 266, m/z 296, and m/z 550 (same as or similar to COX-AA) and m/z 324 and m/z 354 (exclusively from COX-DGLA). Our results suggest that C-15 oxygenation to form PGGs occurs in both COX-DGLA and COX-AA; however, C-8 oxygenation occurs exclusively in COX-DGLA. This new finding will be further investigated for its association with various bioactivities of PGs, with potential implications for inflammatory diseases.

DOI10.1016/j.freeradbiomed.2011.02.001
Alternate JournalFree Radic Biol Med
PubMed ID21310230
PubMed Central IDPMC3073824
Grant ListR15 CA140833-01 / CA / NCI NIH HHS / United States
P30 GM103332 / GM / NIGMS NIH HHS / United States
P20 RR015566 / RR / NCRR NIH HHS / United States
K22 ES012978-03 / ES / NIEHS NIH HHS / United States
1R15CA140833 / CA / NCI NIH HHS / United States
R15 CA140833 / CA / NCI NIH HHS / United States
K22 ES012978 / ES / NIEHS NIH HHS / United States
P20 RR015566-10 / RR / NCRR NIH HHS / United States
K22ES-012978 / ES / NIEHS NIH HHS / United States
5P20 RR015566 / RR / NCRR NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065